Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Peters

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Allergy|August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsDennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
The Medical Journal of Australia|September 6, 2007
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregiversJosephine M Clayton, Karen M Hancock, Phyllis N Butow, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 5, 2018
Development of the International Severe Asthma Registry (ISAR): A Modified Delphi StudyLakmini Bulathsinhala, Nevaashni Eleangovan, Liam G Heaney, et al.
Respirology (Carlton, Vic.)|September 20, 2018
Treatable traits can be identified in a severe asthma registry and predict future exacerbationsVanessa M McDonald, Sarah A Hiles, Krystelle Godbout, et al.
Chest|January 26, 2026
Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials & Real-World DataChandra Prakash Yadav, Laura Huey Mien Lim, David Price, et al.
Chest|February 23, 2024
International Variation in Severe Exacerbation Rates in Patients With Severe AsthmaTae Yoon Lee, David Price, Chandra Prakash Yadav, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2026
Development and validation of the Risk of Exacerbation in Severe Asthma (RESA) modelWenjia Chen, Tae Yoon Lee, David Price, et al.
Chest|April 22, 2021
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma CohortLiam G Heaney, Luis Perez de Llano, Mona Al-Ahmad, et al.
BMC Medical Research Methodology|August 22, 2020
International severe asthma registry (ISAR): protocol for a global registryJ Mark FitzGerald, Trung N Tran, Marianna Alacqua, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Allergy|August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsDennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
The Medical Journal of Australia|September 6, 2007
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregiversJosephine M Clayton, Karen M Hancock, Phyllis N Butow, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 5, 2018
Development of the International Severe Asthma Registry (ISAR): A Modified Delphi StudyLakmini Bulathsinhala, Nevaashni Eleangovan, Liam G Heaney, et al.
Respirology (Carlton, Vic.)|September 20, 2018
Treatable traits can be identified in a severe asthma registry and predict future exacerbationsVanessa M McDonald, Sarah A Hiles, Krystelle Godbout, et al.
Chest|January 26, 2026
Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials & Real-World DataChandra Prakash Yadav, Laura Huey Mien Lim, David Price, et al.
Chest|February 23, 2024
International Variation in Severe Exacerbation Rates in Patients With Severe AsthmaTae Yoon Lee, David Price, Chandra Prakash Yadav, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2026
Development and validation of the Risk of Exacerbation in Severe Asthma (RESA) modelWenjia Chen, Tae Yoon Lee, David Price, et al.
Chest|April 22, 2021
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma CohortLiam G Heaney, Luis Perez de Llano, Mona Al-Ahmad, et al.
BMC Medical Research Methodology|August 22, 2020
International severe asthma registry (ISAR): protocol for a global registryJ Mark FitzGerald, Trung N Tran, Marianna Alacqua, et al.
Pageof 13